Search Results

Benefits of Multispecialty Vascular Care Teams

Combining resources across service lines to bring patients more comprehensive treatment options for complex aortic disease and critical limb ischemia.

By Misaki Kiguchi, MD, MBA, MSc, RPVI; John S. Steinberg, DPM, FACFAS; Christian C. Shults, MD; and Edward Y. Woo, MD

Therapeutic Angiogenesis

Is peripheral arterial disease treatment evolving from stents to stem cells?

By Toshio Matsuhashi, MD; Dara L. Kraitchman, VMD, PhD; and Lawrence V. Hofmann, MD

Radial Access for Peripheral Vascular Procedures

Why and how this approach is used for arterial access in peripheral endovascular procedures.

By John T. Coppola, MD, and Cezar Staniloae, MD

Perspectives on BTK Vessel Prep

BTK versus ATK algorithms, vessel prep decision-making and device selection, impressions on the BTK vessel prep data landscape, and the impact of reimbursement on therapy selection.

With Michel Bosiers, MD; John H. Rundback, MD; Sabine Steiner, MD; and Daniel A.F. van den Heuvel, MD

Endovascular Treatment of Cerebral AVMs

Successful management of cerebral arteriovenous malformations has become a reality.

By Philippe Gailloud, MD

Submassive Pulmonary Embolism: Opportunity Emerging From a Challenging Disease

A presentation of key questions and a discussion of potential next steps in clinical trial development.

By Akhilesh K. Sista, MD

Creating CLI Teams

The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.

By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants

The Challenging Cases Issue

By John A. Kaufman, MD

Venous Disease: The Year in Review

An exploration of significant advances, challenges, and future directions in venous disease management.

By Jacob J. Bundy, MD, MPH; Ravi N. Srinivasa, MD, FSIR; Mark H. Meissner, MD; John M. Moriarty, MD, FSIR; and Jeffrey Forris Beecham Chick, MD, MPH

A Safety Update on Paclitaxel-Coated Devices for Peripheral Vascular Intervention

An overview of the controversy surrounding a late mortality signal associated with paclitaxel-coated devices and an exploration of new data regarding their safety.

By Anna Krawisz, MD, and Eric A. Secemsky, MD, MSc

Establishing a Pulmonary Embolism Response Team

Experts share their advice on the best approach to forming a “PERT” and discuss the benefits that they can offer.

With Ido Weinberg, MD; Michael R. Jaff, DO; James Horowitz, MD; Oren Friedman, MD; Ronald Winokur, MD; Akhilesh Sista, MD; and Keith M. Sterling, MD

Playing Offense in Postthrombotic Syndrome: The C-TRACT Trial Opportunity

Why a randomized controlled trial is important to evaluate iliac vein stenting in PTS and how the C-TRACT trial can help resolve unanswered questions.

By Suresh Vedantham, MD